Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Topical Retinoid, Atralin Gel 0.05% for the Treatment of Erythematotelangiectatic Rosacea

NCT01125930 is registered in ClinicalTrials.gov with Lisa E. Maier as lead sponsor.

NCT NCT01125930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01125930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Topical Retinoid, Atralin Gel 0.05% for the Treatment of Erythematotelangiectatic Rosacea
Lead sponsor
Lisa E. Maier
Phase
Phase 3
Overall status
Terminated
Start date
May 31, 2010
Completion date
January 31, 2013
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rosacea